COVID-19 rapid test SC-1200-10

for antibodiesIgGIgM

Rapid Covid 19 Serological Test for the qualitative detection of IgG and IgM antibodies to 2019-nCov, Sars-CoV-2, Coronavirus virus in human whole blood, serum or plasma samples. For professional in vitro diagnostic use only. The Covid-19 IgG/IgM Screen Test Rapid Serological Test (2019-nCOV), (Sars-CoV-2), is a lateral flow chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies. The new coronaviruses belong to the β strain. COVID-19 is an acute respiratory infectious disease. The population is generally susceptible to it. From what has been observed so far, the main source of new infections are coronavirus infected patients; even infected people without symptoms can be a source of infection. According to current epidemiological investigations, the incubation period is 1-14 days, mostly between 3 and 7 days. The main symptoms include fever, fatigue and dry cough. In some cases, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found. Coronaviruses are a family of coated viruses whose viral genome consists of single-stranded RNA; widely spread among humans, other mammals and birds, they cause respiratory, enteric, hepatic and neurological diseases. The 2019-nCoV IgG/IgM Rapid Cassette Test (Fingerstick Whole Blood) is a qualitative membrane immunoassay for the detection of 2019-nCoV IgG and IgM antibodies in human fingerstick whole blood specimens. This test consists of two components, an IgG component and an IgM component. In the IgG component, anti-human IgG is coated in the area of ​​the IgG test line. During the test, the sample reacts with the 2019-nCoV antigen coated particles inside the test cassette.